Main Responsibilities:
- Lead value assessment of Sanofi ALZ/neurodegenerative assets and external opportunities; recommend price and access assumptions across key markets to support forecasts, business cases, and investment decisions.
- Develop payer value propositions and early market access plans/strategies with competitive differentiation and scenario planning.
- Contribute to Clinical Development Plans and Integrated Evidence Generation Plans to address payer needs aligned to the target value proposition and access risks/mitigation.
- Shape the ALZ ecosystem with Public Affairs and partners to drive payer value recognition by launch for sustainable access.
- Contribute to the Early Neurology Global Market Access Sub-Team to review payer/market insights and co-create strategies.
- Serve as a core member of global project teams and commercial platforms; support formulation/execution of asset strategy and prepare governance meetings (TARC, DWG, IDCC).
- Provide payer insights via market research, advisory boards, early scientific advice, and other platforms to inform strategic and investment decisions.
- Maintain knowledge of relevant scientific/clinical/commercial developments and competitors.
Required Qualifications:
- Advanced degree in life sciences, business, or related discipline.
- Minimum 10 years in pharma/biotech with an accomplished track record in pricing and market access (preferably neurology/neuroscience).
- Experience across payer archetypes in key markets, including deep US market/healthcare system knowledge.
Key Competencies/Skills:
- Strategic leadership; can influence diverse stakeholders in cross-functional teams.
- Strong analytical skills and pricing expertise; translate clinical information into payer access strategies.
- Agility across multiple projects; make recommendations in compressed timelines.
- Business acumen; comfort in ambiguous early-stage settings.
- Outstanding written/oral communication; fluent English.
Benefits:
- High-quality healthcare, prevention/wellness programs, and at least 14 weeksβ gender-neutral parental leave.